Diagnostic efficacy of intravascular ultrasound combined with Gd2O3‑EPL contrast agent for patients with atherosclerosis
- Shuangli Zhu
- Chaoyang Wen
- Dongxue Bai
- Meiying Gao
Affiliations: Department of Ultrasonic Medicine, Beijing Royal Integrative Medicine Hospital, Beijing 102206, P.R. China, Department of Ultrasonic Medicine, Peking University International Hospital, Beijing 102206, P.R. China
- Published online on: October 2, 2020 https://doi.org/10.3892/etm.2020.9265
Copyright: © Zhu
et al. This is an open access article distributed under the
terms of Creative
Commons Attribution License.
Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
This article is mentioned in:
Atherosclerosis is a cardiovascular disease that is pathologically associated with the growth of atherosclerotic plaques and vascular vulnerability. Intravascular ultrasound (IVUS) has been used to evaluate and treat cardiovascular diseases. Accumulating evidence has demonstrated that Gd2O3‑doped nanoparticles contrast can be applied for the diagnosis of human diseases. In the present study, eplerenone (EPL), a mineralocorticoid receptor antagonist, was first doped with Gd2O3 nanoparticles (Gd2O3‑EPL), following which its diagnostic efficacy for use in IVUS measurements (Gd2O3‑EPL‑IVUS) was evaluated for patients suspected with atherosclerosis. Gd2O3‑EPL‑IVUS presented with higher accuracy and sensitivity compared with IVUS in diagnosing 188 patients with suspected atherosclerosis. Gd2O3‑EPL‑IVUS exhibited stronger signals associated with plaque morphology compared with aloe IVUS for patients with atherosclerosis. In addition, Gd2O3‑EPL‑IVUS application resulted in clearer arterial plaque images compared with IVUS by binding mineralocorticoid receptors. Atherosclerosis was subsequently confirmed in all patients using computerized tomography‑coronary angiography. Gd2O3‑EPL‑IVUS showed more accuracy in measuring vessel size, plaque burden and minimal lumen area compared with IVUS analysis alone. In conclusion, these outcomes suggest that Gd2O3‑EPL‑IVUS is a reliable tool for the evaluation of coronary lesions in patients with atherosclerosis.